Radioisotopes

3 trials

Sponsors

Center of Molecular Immunology (CIM), Center of Molecular Inmunology (CIM)

Conditions

Colon/rectum tumorMetastatic breast tumorMetastatic breast tumors.

Phase 2

99mTc-marked 14F7 MaB in metastatic breast, phase II

RecruitingRPCEC00000025

Center of Molecular Inmunology (CIM)Metastatic breast tumor

Start: 2005-10-29Target: 21Updated: 2026-03-30

99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II

RecruitingRPCEC00000069

Center of Molecular Immunology (CIM)Colon/rectum tumor

Start: 2005-05-10Target: 20Updated: 2026-03-30

14F7 MAb marked with Tc99 Phase II in breast tumors.

Active, not recruitingRPCEC00000024

Center of Molecular Immunology (CIM)Metastatic breast tumors.

Start: 2003-02-13Target: 15Updated: 2026-03-30